-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $22

Benzinga·02/24/2026 19:22:05
Listen to the news
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.